Thyroid Associated Ophthalmopathies Clinical Trial
Official title:
Phase 3 Study of Treatment of Soft Tissue Expansion and Exophthalmos in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues.
Prostaglandin analogues eye drops are common and effective treatment for decreasing Intra-Ocular Pressure (IOP) in Glaucoma patients. A number of recently published case reports have documented periorbital fat atrophy following treatment by prostaglandin analogues. In this study the investigators want to use this side-effect of prostaglandin analogues for the treatment of orbital and periocular fat proliferation in inactive Thyroid eye disease (TED) patients, as a conservative substitute for surgical intervention.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT02112643 -
Selenium in Mild Thyroid Eye Disease in North America
|
Phase 3 | |
| Completed |
NCT01297699 -
Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease)
|
Phase 3 | |
| Completed |
NCT01868997 -
Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease
|
Phase 2 |